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Abstract: A mathematical model has been developed to assist with the development of a hollow fibre 
bioreactor (HFB) for hepatotoxicity testing of xenobiotics; specifically, to inform the HFB operating set-up, 
interpret data from HFB outputs and aid in optimizing HFB design to mimic certain hepatic physiological 
conditions. Additionally, the mathematical model has been used to identify the key HFB and compound 
parameters that will affect xenobiotic clearance. The analysis of this model has produced novel results that 
allow the operating set-up to be calculated, and predictions of compound clearance to be generated. The 
mathematical model predicts the inlet oxygen concentration and volumetric flow rate that gives a 
physiological oxygen gradient in the HFB to mimic a liver sinusoid. It has also been used to predict the 
concentration gradients and clearance of a test drug and paradigm hepatotoxin, paracetamol (APAP). The 
effect of altering the HFB dimensions and fibre properties on APAP clearance under the condition of a 
physiological oxygen gradient is analysed. These theoretical predictions can be used to design the most 
appropriate experimental set up and data analysis to quantitatively compare the functionality of cell types 
that are cultured within the HFB to those in other systems. 
Key words: Hollow Fibre Bioreactor; Liver Zonation; Hepatotoxicity testing. 
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Introduction 
A considerable variety of screens are utilised in in vitro hepatotoxicity studies, including human and non-
human tissue slices, primary hepatocytes (freshly isolated and cryopreserved; suspension and 2D culture), 
transformed liver cell lines, CYP-engineered cells, stem cell-derived hepatocytes and liver co-cultures.  Drug 
bioactivation is thought to play a significant initiating role in the hepatotoxic mechanism of numerous 
drugs.  Consequently a major consideration, when selecting an in vitro system for drug toxicity screening, is 
the normal expression and retention of xenobiotic metabolising enzymes.  However, current in vitro 
systems show reduced liver-specific functions, in particular loss of cytochrome P450 activity (Godoy et al., 
2013). It is expected that in vitro systems that mimic physiological conditions (for example in three rather 
than two dimensions, employing flow and nutrient gradients etc) will generate data that gives better 
predictions of the toxicity of xenobiotics.  
Much focus and effort is being invested on the generation of in vitro systems for use in the safety 
assessment of new chemicals, with a growing shift in focus to human relevancy, rather than the historical 
approaches of using high doses in animals and extrapolating these to low exposure potential effects in 
humans. Many local exposure models exist, but there remains a significant need for dose-dependent 
systemic toxicity readouts and endpoints, such as those often seen in hepatotoxicity. Early studies using 
animal-derived primary cells can provide a route by which to validate these models using existing historical 
data, with the long term objective to use human cells to better predict in vivo exposure and thus potential 
toxicity in humans. Development of reliable, species-relevant and thus more predictive in vitro systems will 
not only produce better quality scientific data in the future but also reduce the often large numbers of 
animals used for these types of toxicity testing, with associated minimisation in time and cost to 
companies.  
However, setting the operating conditions and choosing the most appropriate design to mimic physiological 
environments in such systems purely by experimental trial and error would be difficult, costly and time 
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consuming. Also, assessing the behaviour of individual cells in systems that are by necessity spatially 
heterogeneous would require intensive experimental effort to accomplish.  In these situations, theoretical 
models can provide insights, e.g. by interpolating experimental measurements to provide spatial 
information—thus reducing the number of measurements required—and aiding in the experimental design 
of these novel systems by determining theoretical relationships between the parameters and experimental 
observations. 
Physiologically, the liver plays a key role in integrating fuel storage, endogenous metabolism, particularly 
lipid and glutathione metabolism, and requires significant O2 to perform this role (Suzuki, Shinjo, Arai, 
Kanai, & Goda, 2014). This results in steep oxygen gradients across liver lobules and a high sensitivity to 
local oxygen concentrations. Hepatocytes make up 80-85% of the liver and are responsible for the majority 
of liver xenobiotic metabolism; they are arranged along short capillaries known as liver sinusoids. The 
function of hepatocytes is heterogeneous along the sinusoid and the oxygen gradient within the sinusoid is 
thought to play a key role in this heterogeneous functionality—the blood oxygen partial pressure ranges 
from 65 mmHg at the sinusoid inlet to 30 mmHg at the outlet (Jungermann & Kietzmann, 2000). The ability 
to model a hepatic sinusoid in vitro, recapitulating oxygen-sensitive functionality is crucial for 
understanding zonal responses to hepatotoxins and hepatic disease. Hepatic hypoxia is a key feature of a 
number of medical conditions, and has been implicated in the development of both alcoholic and non-
alcoholic fatty liver disease (Suzuki et al., 2014). 
In vitro test systems that attempt to replicate this heterogeneous liver environment show improved 
hepatocyte functionality compared to traditional two-dimensional culture systems (Allen, Khetani, & 
Bhatia, 2005). Bioreactors that use flow to induce an oxygen gradient have also shown heterogeneous 
distributions of cytochrome P450 enzymes—a family of metabolising enzymes frequently implicated in the 
formation of harmful reactive metabolites—that correlate to those seen in vivo (Allen et al., 2005). Hollow 
fibre bioreactor (HFB) systems incorporate physiological features such as flow and oxygen gradient 
required to represent a liver sinusoid in vitro and have shown promise for use as bioartificial livers 
(Jasmund, Langsch, Simmoteit, & Bader, 2002; Lu et al., 2005). Extending HFB for hepatotoxicity testing is 
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therefore a natural extension of this work but obviously requires validation to determine first whether the 
HFB can recapitulate the hepatic sinusoidal oxygen gradient and subsequent cell zonation. 
Primary human hepatocytes in monolayer cultures are generally still considered the gold standard in vitro 
model for metabolism studies and toxicity investigations (Kyffin et al., 2018). However, there are a number 
of problematic issues with this system, the main one being that this classical 2D/monolayer cell culture 
does not recapitulate the zonated 3D in vivo liver micoenvironment. Much research has therefore been 
directed towards designing more in vivo like 3D test systems. The most commonly used liver models are 
liver slices (Lerche-Langrand & Toutain, 2000), spheroids (Soldatow, LeCluyse, Griffith, & Rusyn, 2013), 
scaffold and hydrogel technologies (Tibbitt & Anseth, 2009), liver organoids (Nantasanti, de Bruin, 
Rothuizen, Penning, & Schotanus, 2016) and micro-fluidic test systems (Rothbauer, Zirath, & Ertl, 2018) – a 
cross comparison of the advantages and disadvantages of these different systems are reviewed in (Kyffin et 
al., 2018). As regards to the bioreactor system the main advantages are that: 1) liver cell lines (such as 
HepG2) cultured in this system show improved phase I metabolism compared to static 2D experiments; 2) 
cells on the bioreactor are polarised and form functional bile canalicular; 3) it is possible to achieve in vivo 
like liver sinusoidal zonation; 4) the cells are protected from shear stress due to being cultured on the 
outside of the fibre membrane (analogous to the endothelial cell lining in vivo) (Storm et al., 2016). The 
main limitations, however, of the bioreactor system are that it’s costly and low throughput system 
compared to, for example, 3D spheroids or the classical 2D sandwich or monolayer cultures, plus there are 
well known issues regarding cell attachment on such cylindrical fibres (Storm et al., 2016).  
The strategy we adopted was to use paracetamol (APAP) as a paradigm hepatotoxin to assess the phase I 
and II metabolic functionality of cells within the HFB for comparison with other in vitro test systems. APAP 
is a well understood hepatotoxin (Bessems & Vermeulen, 2001; Hinson, Roberts, & James, 2010) and has 
been used as such in many experimental studies including other bioreactors (Allen et al., 2005; Prot et al., 
2011; Xia et al., 2009). It undergoes both phase I metabolism—via CYP450 enzymes to a harmful reactive 
metabolite (NAPQI, N-acetyl-p-benzoquinone imine) — as well as phase II metabolism. This makes APAP an 
ideal test compound to assess the HFB against other systems. 
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In the present study a mathematical model is proposed to (a) set operating conditions for a HFB to achieve 
a more physiologically-relevant cellular environment and (b) quantitatively assess cellular functionality with 
respect to APAP metabolism. The mathematical model comprises a system of partial differential equations 
(PDEs) that describe the relationships between the inlet oxygen concentration, flow rate, cell density and 
the oxygen gradient along the HFB—this is similar to previous models of oxygen consumption in HFBs for 
use as bioartificial livers (Davidson, Ellis, & Chaudhuri, 2010, 2012; Shipley et al., 2011) . By changing these 
parameters the system can be optimised such that the oxygen gradient along the HFB mimics that along a 
liver sinusoid in vivo. In addition, the metabolism of APAP within the HFB has been mathematically 
modelled so that we can predict how the design of the HFB—dimensions, fibre permeability and cell 
density—will impact on the concentration gradient of APAP along the HFB.  
Mathematical models for APAP metabolism have been published previously (Diaz Ochoa et al., 2012; Pery 
et al., 2013; Reddyhoff, Ward, Williams, Regan, & Webb, 2015; Reith et al., 2009; Remien, Adler, 
Waddoups, Box, & Sussman, 2012; Williams et al., 2013) that use various forms of kinetics to represent the 
metabolism pathways - these include linear approximations and single and double substrate Michaelis-
Menten functions. In this paper, we use single substrate Michaelis-Menten kinetics to represent the three 
main pathways of APAP metabolism: sulphation, glucuronidation, and CYP activation. We predict how the 
design parameters and operating conditions of the HFB impact on the observed clearance rates of APAP. 
This is important for comparing the functionality of cells within the HFB to other in vitro test systems and 
for extrapolating the results to in vivo systems. It is also useful for optimizing the design of the HFB for 
specific experimental tasks. 
In addition, an analytical approach (Shipley et al., 2011) that gives a solution applicable when the 
metabolism kinetics are approximately constant has been extended to give a novel analytic solution 
applicable when the metabolism kinetics are linear. This can then be applied to give an approximate 
analytic solution when the metabolism kinetics are non-linear by using a piecewise linear approximation to 
the metabolism function. This allows the operating conditions of the bioreactor to be determined in a more 
accessible form that does not require proprietary numerical software to solve PDEs.  
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Methods 
The current design of the bioreactor consists of a single hollow fibre contained within a glass cylinder. The 
fibre is a synthetic porous membrane containing a hollow central lumen and surrounded by a monolayer of 
confluent cells. The region outside of this, contained within the glass cylinder, is referred to as the extra-
capillary space (ECS). Let z be the axial direction down the lumen centreline, with z = 0 at the inlet and z = L 
at the outlet. The radius of the lumen is denoted by d, the depth of the membrane by s and the depth of 
the ECS is by l. Figure 1 shows a schematic of the bioreactor; we have assumed radial symmetry so that 
there is no aximuthal variation in the geometry of the HFB, and denote the radial coordinate by r, with r=0 
corresponding to the lumen centreline. The dimensions of the bioreactor for initial testing (and typical of 
experimental values used) will be L = 0.1 m, d = 300 µm, s = 200 µm, l = 100 µm, with these values subject 
to change depending on design criteria and mathematical predictions. The dimensions of the bioreactor 
were selected so that, with the given cellular O2 consumption rates and pump flow ranges, the oxygen 
gradient along the length of the bioreactor recapitulated the 65mmHg (at the inlet) to 30mmHg (at the 
outlet) gradient observed in the real in vivo liver sinusoid. We assume a cell layer surface density of ρ = 
1.32×109 cells per m2 based on assuming the area of membrane occupied by a hepatocyte is a regular 
hexagon with maximal diameter 34.2×10-6m (Katayama, Tateno, Asahara, & Yoshizato, 2001); we explore 
small variations in this density to investigate the uncertainty in the cell seeding process and the shape of 
individual hepatocytes within the monolayer. Parameter values for both oxygen and APAP transport are 
summarised in Table 1. The membrane offers resistance to diffusion of compounds through it compared to 
free space, dependent on the pore size and tortuosity of the membrane material; we capture this through a 
membrane hindrance factor, h=10, such that Dm = Dl/h for both oxygen and APAP (and subsequently 
explore the sensitivity of model predictions to variations in h).  
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Figure 1: Schematic of a hollow fibre bioreactor. The fibre consists of a single fibre shown in radial (left) 
and axial (right) cross section. Cells are seeded in a confluent monolayer on the outer membrane surface 
(r=d+s). Culture medium is pumped into the lumen inlet at z=0, and exists via the lumen exit at x=L. A 
typical fluid velocity profile is shown on the right. 
 
Table 1: Parameters for Oxygen and APAP. aTo convert Vmax units from source, a rat liver volume fraction of 
0.037  (Pery et al., 2013) has been used. 
Parameter Value Source 
Oxygen   
Dl and De 3×10-9m2s-1 (Shipley et al., 2011) 
Dm = Dl/h 3×10-10m2s-1 (Shipley et al., 2011) 
Rat In Vivo Hepatocytes:   
Vmax 1.76×10-3mol m-3s-1 (Shipley et al., 2011) 
Km 6.24×10-3mol m-3 (Shipley et al., 2011) 
   
Paracetamol (APAP)   
Dl and De 0.65×10-9 m2s-1 (Ribeiro et al., 2012) 
Dm = Dl/h 0.65×10-10 m2s-1 - 
Primary Rat Hepatocytes:   
Glucuronidation Vmaxa 2.4×10-3mol m-3s-1 (Pery et al., 2013) 
Glucuronidation Km 0.915 mol m-3 (Pery et al., 2013) 
 
Fluid (culture medium) enters the system through the lumen inlet (z=0) at a designated constant flow rate 
and exits via the lumen outlet (z=L); there is no flow of fluid in the membrane or ECS spaces. Although 
other compounds are contained within the media, we only consider the transport of oxygen and the 
hepatotoxin (here APAP). In the lumen, compounds are transported by both advection and diffusion, 
whereas diffusion is the only transport process in both the membrane and the outer cylinder. We also 
assume that cells form a confluent monolayer that is fixed in time. This is a reasonable approximation as on 
the timescale we are considering for transport processes, cell proliferation and death are quasi-steady. The 
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cell monolayer is thin compared to the lumen radius and membrane, ECS depths (10 µm compared to 100-
300 µm), therefore we assume that the compound concentration in the cell layer is constant in the radial 
direction normal to the membrane surface. Indeed, in the experimental set-up (see (Storm et al., 2016)), 
the cells are observed to flatten to form a single cell monolayer on the outside of the fibre therefore such a 
thin boundary layer assumption seems valid. There may be cases (e.g. different cell types) where the cells 
may grow and form multiple layer cell structures on the outside of the fibre.  In which case, multiple layers 
of cells can be included in the model as multiple radial compartments within the PDE framework and it is 
possible that an analytic solution could be computed for this case using similar methods as to those used in 
this paper, but this is beyond the scope or focus of this current work. Under the thin boundary layer  
assumption the metabolism of compound by the cells can be modelled as a jump condition in the flux at 
the membrane/ECS boundary (this assumption was verified numerically compared to one where the cell 
layer thickness was explicitly accounted for, with details provided in the Supplementary Material).  
We also assume that the intrinsic clearance rate of a compound is independent of the oxygen level. There is 
experimental evidence that the rates of the main APAP metabolism pathways of sulphation and 
glucuronidation are independent of the position of the cell along the sinusoid, which implies they are also 
independent of the oxygen concentration (Anundi, Lahteenmaki, Rundgren, Moldeus, & Lindros, 1993). This 
is not the case for the turnover of APAP by CYP activation—which is heterogenous along the sinusoid (Allen 
et al., 2005)— however, this is a relatively minor pathway for considerations of APAP elimination, with 
around 5% of APAP being metabolised through this pathway (Remien et al., 2012; Siegers, Rozman, & 
Klaassen, 1983). 
Fluid flow in the lumen is within a low reduced Reynolds number regime, and we follow the approach of  
(Shipley et al., 2011) and describe it using Poiseuille flow so that the fluid velocity, u = 2U(1-r2/d2)ez , where 
U  is the mean velocity (ms-1) and ez is the unit vector in the z-direction. Both oxygen and APAP are 
modelled by the same set of conservation equations differing only in values of the respective diffusion 
coefficients and the Michaelis-Menten constants that parameterise cellular metabolism, as given in Table 1. 
We denote the concentration of chemical (here either oxygen or APAP) by c (mol m-3) with subscripts l, m, 
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and e denoting the values in the lumen, membrane and extra-capillary space. The steady state conservation 
equations in each region are: 
 ∇ ∙ (𝑐𝑙𝒖) = 𝐷𝑙∇
2𝑐𝑙 in the lumen, (1) 
 0 = 𝐷𝑚∇
2𝑐𝑚 in the membrane, (2) 
 0 = 𝐷𝑒∇
2𝑐𝑒 in the ECS, 
 
(3) 
where Dl, Dm, and De are the diffusion coefficients in the lumen, membrane and ECS respectively—all 
assumed constant, with units m2s-1. It is necessary to specify boundary conditions on the external 
boundaries of the bioreactor and between its internal regions. Continuity of concentration and flux is 
imposed upon the boundaries between the lumen and membrane, given by  
 𝑐𝑙 =  𝑐𝑚 and 𝐷𝑙∇𝑐𝑙 ∙ 𝒏 = 𝐷𝑚∇𝑐𝑚 ∙ 𝒏 on the lumen/membrane boundary, r=d, (4) 
where n is the outward pointing unit vector normal to the relevant surface. Continuity of concentration is 
also imposed upon the boundary between the membrane and ECS and the metabolism of compound by the 
cells is represented by a jump condition in the flux at this boundary. This gives 
 𝑐𝑚 = 𝑐𝑒 and  
1
𝜑
(𝐷𝑚∇𝑐𝑚 ∙ 𝒏 − 𝐷𝑒∇𝑐𝑒 ∙ 𝒏) = 𝑅(𝑐𝑚) 
on the membrane/ECS boundary, r=d+s, 
(5) 
 where 𝜑 = 𝜌𝑣hep with the volume of a hepatocyte 𝑣hep = 6.98×10
-15m3 (Plettenberg, Weiss, Lemor, & 
Wehner, 2008) and R(c) (mol m-3s-1) is a function representing cellular metabolism—this will typically be a 
Michaelis-Menten function. A zero flux condition is imposed on the outer ECS boundary, that is, 𝐷𝑚∇𝑐𝑚 ∙
𝒏 = 0 on r=d+s+l. This represents no transport out of the glass cylinder. At the lumen inlet (z = 0) the 
concentration is given by cl = cin, where cin is a fixed concentration prescribed experimentally to give 
appropriate functionality within the bioreactor. Zero diffusive flux is also imposed on the ends of the 
bioreactor at z = 0, L within the membrane and ECS domains (which are closed there), and at z=L within the 
lumen (which imposes a minimal restriction on the lumen concentration field). The steady state of this PDE 
system of equations (1)-(5) can be solved numerically—we have done this using the COMSOL Multiphysics 
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software package—but for a linear cellular metabolism function an explicit analytic solution has also been 
derived.  Furthermore, this solution can be applied to an arbitrary metabolism function provided it is 
differentiable. The full details of the derivation of the analytic solutions are in the Supplementary Materials 
with a brief summary below. The COMSOL simulations were carried out with a mesh containing 698 
elements (the mesh was refined up to 1964 elements with no change in the concentration predictions to 2 
significant figures). 
To make progress analytically the system of equations given by (1)-(5) is reduced asymptotically by 
exploiting the small aspect ratio of the fibre defined by 𝜀 =
𝑑
𝐿
≈ 3 × 10−3 ≪ 1, and integrating the 
resulting equation set. Note that although the lumen radius d and length L can be varied in the design of 
the HFB, 𝜀 ≪ 1 will always hold. For the simplification to be valid a second condition must be met; the 
reduced Péclet number 𝑃𝑒 =
𝑈𝑑2
𝐿𝐷𝑙
≈ 0.1 should satisfy 𝑃𝑒 > 𝑜(𝜀). This condition is equivalent to ignoring 
diffusion in the axial z-direction due to a combination of the dominance of advection in the lumen and the 
small aspect ratio. This simplification process and the criticality of the reduced Péclet number have been 
previously used and discussed in (Shipley et al., 2011; Shipley, Waters, & Ellis, 2010).  
We have derived explicit analytic steady-state solutions to the system of equation (1)-(5) in the cases where 
the metabolism function 𝑅(∙) is linear, that is 𝑅(𝑐𝑒) = 𝐴𝑅𝑐𝑒 + 𝐵𝑅,for constants 𝐴𝑅 and 𝐵𝑅, and also where 
the cellular metabolism is represented by a Michaelis-Menten function of the form 𝑅(𝑐𝑒) = 𝑉𝑚𝑎𝑥𝑐𝑒/(𝐾𝑚 +
𝑐𝑒), where Vmax is the maximum velocity and Km is the Michaelis-Menten constant, given by the 
concentration at which the reaction rate is half maximal. The metabolism functions of oxygen and APAP are 
represented here by Michaelis-Menten functions in common with other work for oxygen (Davidson et al., 
2010; Hay, Veitch, & Gaylor, 2001; Shipley et al., 2011) and for APAP (Pery et al., 2013; Reith et al., 2009).  
For Michaelis-Menten metabolism functions, the analytic solutions can be used to approximate compound 
gradients in three different ways. The most suitable method depends on the parameter Km and the 
concentration of compound within the bioreactor at the cells:    
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1. If 𝑐𝑒 ≫ 𝐾𝑚, then the zero order approximation 𝑅(𝑐𝑒) ≈ 𝑉𝑚𝑎𝑥 is applicable. The can then be used to 
calculate the compound gradient by letting 𝐴𝑅 = 0, 𝐵𝑅 = 𝑉𝑚𝑎𝑥 (this is analogous to the analytic 
solutions for a zero order approximation previously derived by the same method (Shipley et al., 2011)).  
2. If 𝑐𝑒 ≪ 𝐾𝑚 then the first order approximation 𝑅(𝑐𝑒) ≈
𝑉𝑚𝑎𝑥𝑐𝑒
𝐾𝑚
 is applicable. In this case, the solution 
can be used to calculate the gradient by letting 𝐴𝑅 =
𝑉𝑚𝑎𝑥
𝐾𝑚
, 𝐵𝑅 = 0.  
3. If neither the first order nor zero order approximations are applicable, or greater accuracy is required, a 
piecewise linear approximation scheme can be implemented to compute the compound gradients. This 
procedure can be applied to an arbitrary metabolism function as long as it is differentiable and full 
details of method are given in the Supplementary Materials. A version of this is also implemented in the 
Excel spreadsheet in the Supplementary Materials, which could be applied by an end-user, for example, 
to characterise the concentration fields in their bioreactor. 
The average clearance per cell is used as a measure of observable cell functionality within the bioreactor 
that could be measured experimentally from the outlet concentration of compound leaving the bioreactor. 
If Qin is the molar amount of compound entering the HFB inlet per second, Qout is the quantity of compound 
leaving the HFB outlet per second and Tcells is the total number of cells in the bioreactor, then the average 
clearance per cell is calculated by (Qin –Qout)/Tcells.  
Results 
Simulations for predicted concentrations of oxygen and APAP within the bioreactor are shown in Figure 2. 
The input oxygen concentration and fluid flow rate have been set to reproduce physiological oxygen 
gradients within the bioreactor at the cell density simulated. The predicted clearance of APAP under these 
conditions is also shown. The parameters that determine the rate of clearance—that is the parameters for 
sulphation, glucuronidation—are based on in vivo estimates (Pery et al., 2013). The cells are predicted to 
clear over 50% of the inlet concentration of APAP which is similar to what has been seen in liver perfusion 
studies of isolated whole rat livers (Pang, Barker, Simard, Schwab, & Goresky, 1995), where clearances of 
50% have been observed. Hepatocytes in vitro typically have reduced functionality compared to 
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hepatocytes in vivo. Figure 3 shows predicted APAP clearance rates in an HFB populated by cells that have 
elimination rates calculated from literature in vitro studies carried out in conventional 2D well-plate 
systems (rat and cryopreserved human hepatocytes in suspension (Naritomi, Terashita, Kagayama, & 
Sugiyama, 2003)), as well as a microfluidic in vitro platform (Prot et al., 2011) and in vivo with clearance 
rates calculated from relevant PBPK models (Pery et al., 2013; Watari, Iwai, & Kaneniwa, 1983). The 
relationship between elimination rates of APAP by the cells and the average clearances within the HFB are 
shown in Figure 3B. Expressed on a log-log scale, this relationship is approximately linear with slope 
decreasing slightly with increasing intrinsic clearance. The corresponding radial APAP concentration 
changes at the outlet of the HFB are shown in Figure 3A. This shows a marked difference in concentration 
between the lumen (r < 3×10-4m) and the cell layer (r = 5×10-4m) for cells with a high elimination rates for 
APAP. This means that differences between cell types and in vitro test systems can be clearly observed by 
taking account of the concentration of the remaining compound in the media at the outlet flow of the HFB 
(and thereby determining average HFB clearance) as well as the radial compound gradient within the 
bioreactor. These results also highlight the magnitude of the differences between cell functionalities in 
some current in vitro systems compared to that in vivo, and the gap that we are attempting to fill with this 
new optimised HFB system. The goal is to achieve average clearances from cells in the HFB at levels 
comparable to that predicted for in vivo and the aim of this mathematical modelling is to optimise the HFB 
to recapitulate the best physiologically representative conditions in the HFB to achieve this.  
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Figure 2: Numerical simulation of concentration gradients of oxygen and APAP within the bioreactor. (A) 
Oxygen and (B) APAP within a hollow fibre bioreactor seeded with primary rat hepatocytes with zonal 
regions indicated. The mean flow rate along the lumen was U = 0.0005ms-1. The inlet concentrations of 
oxygen and APAP were 67 mmHg and 0.1 mol/m3 respectively. Other bioreactor parameters were L = 0.1m, 
d = 3×10-4m, s = 2×10-4m, l = 1×10-4m. 
 
 
Figure 3: Predictions of radial concentrations of APAP in the HFB outlet and clearance rates determined 
in different  in vitro and in vivo models. (A) Radial concentrations of APAP at the HFB outlet and (B) 
average clearance rates with elimination rates determined from different hepatocyte systems—rat in vivo 
(Pery et al., 2013; Watari et al., 1983), rat and cryopreserved human cells in suspension (Naritomi et al., 
2003) and cryopreserved human hepatocytes in a microfluidic in vitro platform . In order to incorporate 
these experimental elimination rates (𝑘𝑒𝑙; measured with units per second) in the model, the APAP 
metabolism term is reduced to linear/first order approximation form, 𝑉 = 𝑘𝑒𝑙𝑐𝜑, with 𝜑 = 𝜌𝑣ℎ𝑒𝑝 and 
𝑘𝑒𝑙 = 4.58 × 10
−2 𝑠−1 (Rat Wistar in vivo (Watari et al., 1983)); 𝑘𝑒𝑙 = 1.732 × 10
−2 𝑠−1 (Rat Sprague 
Dawley in vivo (Pery et al., 2013));  𝑘𝑒𝑙 = 7.707 × 10
−4 𝑠−1 (Cryo human Biochip (Prot et al., 2014)); 𝑘𝑒𝑙 =
2.483 × 10−4 𝑠−1 (Rat suspension (Naritomi et al., 2003)); 𝑘𝑒𝑙 = 1.2916 × 10
−5 𝑠−1 (Cryo human 
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suspension (Naritomi et al., 2003)). APAP dose is 1 mol/m3 and the other parameters are as given in Table 
1. 
 
The different methods for computing steady state concentrations are compared in Figure 4. The analytic 
solution with a zero order approximation (Figure 4A) and first order approximation (Figure 4B) agree well 
with the numerical solution of the full system of PDEs computed using COMSOL. The analytic solutions do 
predict a lower concentration within the bioreactor but this is to be expected as the zero order and first 
order approximations both give a higher clearance rate than the Michaelis-Menten function from which 
they are derived. There is extremely good agreement between the solution computed from solving the full 
system of PDEs numerically and the one computed by the piecewise scheme;  percentage errors are less 
than 0.25% for a scheme using ten linearization steps—details of the percentage error calculation is 
contained in Supplementary Material.  
 
Figure 4: Comparison of numerical and analytic approaches. Concentration of compound at inlet (z = 0, 
blue), midpoint (z = L/2, green) and outlet (z = L, red) of bioreactor with cellular consumption governed by a 
Michaelis-Menten reaction with (A) low Michaelis constant Km = 6.24 ×10-3 mol/m3 and (B) high Michaelis 
constant Km = 1 mol/m3. Solid lines are computed numerically using COMSOL, dashed lines are the 
appropriate analytic approximation—(A) zero order and (B) first order—and crosses (×) are computed using 
the piecewise linear scheme. In (A) Vmax = 1.76×10-3 mol m-3s-1 and in (B) Vmax = 7×10-3 mol m-3s-1 . All other 
parameters identical between (A) and (B) and given in Table 1. 
 
We have carried out analysis to understand how sensitive clearance rates within the HFB are to variations 
in HFB design and operation parameters (Figure 5). The relationship between volumetric flow rate and the 
radius of the lumen, membrane hindrance factor and depth that results in a fixed oxygen gradient is shown 
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in Figure 5. To mimic physiological conditions the oxygen partial pressure at the cell layer at the inlet end of 
the HFB is set to be 65 mmHg, whilst at the outlet end it is set to be 30 mmHg by adjusting the flow rate of 
media down the lumen and the inlet oxygen concentration. We have also looked at how sensitive the 
clearance rates are to changes to the volumetric flow rate that result in an oxygen outlet concentration at 
the cells of up to plus or minus 10% of the base level. Within this range the clearance of APAP has been 
plotted (Figure 5). The relationship between the length of the HFB and the volumetric flow rate required to 
maintain a fixed oxygen gradient has been calculated analytically. In the analytic solutions, length L and 
flow rate U only appear in the Péclet number 𝑃𝑒 =
𝑈𝑑2
𝐿𝐷𝑙
. Therefore, increasing both the average velocity in 
the lumen and the HFB length by the same proportional amount will produce an identical concentration 
gradient. The three colour plots, Figures 5 A, C and E, show that altering the volumetric flow rate to give an 
oxygen concentration up to plus or minus 10% of the base level has little effect on the predicted average 
clearances.  
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Figure 5: Sensitivity analysis of the HFB model. Relationship between either volumetric flow rate (A, C, E) 
or inlet lumen oxygen concentration (B, D, F) and lumen radius (A, B), membrane depth (C, D) and 
membrane hindrance factor (E, F), shown together with average clearance of APAP (A, C, E).  Solid black line 
(A, C, E) indicates where the oxygen concentration at the cell monolayer is the base level of 0.12 mol/m3 at 
the inlet end of the bioreactor and 0.054 mol/m3 at the outlet end. The dashed black lines indicate where 
the oxygen levels are 10% above or below the base level. The colour map shows the average clearance of 
APAP. The inlet concentration of APAP is 1mol/m3. Other parameters are as given in Table 1.  
 
If the HFB lumen radius is varied (and other geometry/ operating conditions chosen to give the same 
oxygen gradient at the cell layer), the average clearance rates will remain very similar (Figure 5 A), 
independent of the APAP dose (also see Figure 3 A in supplementary materials). This suggests that the 
radius of the lumen can be determined by other considerations such as the number of cells—a larger radius 
will result in a larger outer membrane surface area and require more cells to form a confluent monolayer—
that will be influenced by the seeding method, cell growth rates and the sensitivity of the measurements of 
the system outputs. In Figure 5B, the key result is that a lower lumen inlet O2 concentration is needed to 
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maintain 65mmHg at the inlet part of the cell layer when the radius of the lumen is larger.  At smaller 
lumen radii, there is a lower total amount of oxygen available to the cells, so the lumen input concentration 
needs to be increased to compensate. At higher lumen radii, depletion doesn’t occur so the required lumen 
oxygen concentration remains relatively constant. 
There is a more significant difference in average clearance rates for HFBs that differ in membrane depth 
(Figure 5 C) and this especially true at low doses of APAP where the concentration gradient in the 
bioreactor will be large relative to the inlet concentration (also see Figure 3 B in supplementary materials). 
This is due to the relative rates of diffusive and advective transport in the lumen and membrane. This can 
be seen in Figure 3 A where concentration decreases rapidly radially in the membrane due to the slower 
rate of diffusion compared to the total transport in the lumen. To achieve the same oxygen gradient for 
different membrane depths requires adjustments in volumetric flow rate and inlet oxygen concentration as 
shown in Figure 5 C and D respectively. To adjust the input concentration of an arbitrary compound to 
achieve a particular concentration at the cells at the inlet end would require detailed knowledge of the 
compound consumption/turnover rates of the cells within the HFB. If the volumetric flow rate is fixed by 
the oxygen concentration it would then not be possible to set the gradient of the second compound 
arbitrarily and this must be factored into the experimental design using the mathematical model 
predictions for guidance.  
Altering the hindrance factor, h, that characterises membrane diffusion also has an impact on average 
clearance, with the effect more pronounced for low doses of APAP (Figure 5 E and supplementary Figure 
3C). This is important if the hindrance factor increases during the operation of the bioreactor due to 
chemical and protein fouling. The oxygen gradient can be maintained by adjusting the flow rate but this will 
impact upon the clearance of APAP especially at low doses. For Figures 5E and F, hindrance factor doesn’t 
have such a big effect because the rate of diffusion across the membrane isn’t strongly limiting for the 
equilibrium. That is, it might take longer to reach equilibrium with a higher hindrance factor but the oxygen 
concentration at the cell layer is mainly determined by the amount of oxygen coming in, at the lumen 
input, and the number of cells consuming it. It is important to note that varying the membrane depth and 
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the lumen radius change the number of cells so they will both have a bigger impact on the oxygen 
concentrations and subsequently how much this needs to be compensated for by the changing flow rate 
and inlet oxygen concentration. The equilibrium concentrations are less sensitive to the rate at which 
oxygen is transported across the fibre membrane, but the time to reach the equilibrium will clearly be 
impacted. 
At low doses the average clearance of APAP is also significantly affected by the density of cells (Figure 1 
Supplementary Materials) even when the volumetric flow rate through the HFB is being controlled to 
ensure the same oxygen concentration.  An increase in the cell density (and therefore cell metabolism) 
must be compensated by an increase in flow rate to maintain the oxygen gradient. However, due to the 
differences in diffusivity between APAP and oxygen the average clearance per cell of APAP will decrease.  
To consider bioreactor operation for compounds other than APAP, we have carried out simulations where 
the diffusivity of our test compound is varied (Figure 2 Supplementary Materials). A proportional change in 
diffusivity can be considered as the reciprocal of the same proportional change in the Stokes radius of the 
compound. Our simulations show that compounds with a similar rate of intrinsic clearance to APAP but a 
lower diffusion coefficient will have a lower total clearance in a HFB than APAP if they are administered at 
the same dose. This difference is not greatly affected by the membrane hindrance factor. However, low-
clearance compounds—compounds with a long in vivo half-life—have a total HFB clearance that is less 
dependent on the diffusion coefficient. Two low clearance compounds with a similar intrinsic clearance rate 
will have similar total HFB clearances even if there is a marked difference in their diffusion coefficients. This 
is shown in the simulations of a compound with varying diffusion coefficient and a metabolism Vmax that is 
10% that of APAP. 
Discussion 
Currently hepatotoxicity screens that use two dimensional cultures or suspensions of primary hepatocytes 
and hepatic cell lines show reduced metabolic functionality compared to liver cells in vivo—for example 
primary hepatocytes rapidly lose CYP450 after isolation (Boess et al., 2003; Michalopoulos, Sattler, & Pitot, 
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1976). Three dimensional systems incorporating more realistic physiology have shown increased expression 
of these enzymes—such as the CYP450 family of enzymes (Allen et al., 2005). However, it is inherently 
more complex to determine the metabolic activity in three dimensional systems and there is no standard 
for comparing the metabolic functionality of cells of different types, used in different environments. 
Measuring enzyme proteins and mRNA is invasive—which is not ideal for a low-throughput device such as a 
HFB—and does not necessarily translate into functionality. Determining the rate of cellular compound 
turnover in a 3D system with flow is complicated by the cells not all being subject to the same external 
concentration—rates of metabolism, toxicity and often transport are typically concentration dependent. 
The analytic solutions presented here allow for the computation of chemical and compound gradients 
within the bioreactor using only measurements of inlet and outlet concentrations. These solutions have the 
advantage of being suitable for spreadsheets and purpose-built applications without the need for 
proprietary software.  This will allow users of the HFB to access the modelling to calculate the operating 
conditions for their particular cell type, set up and experimental requirements. Principally this is through 
the calculation of the inlet oxygen concentration and flow rate required to achieve a fixed oxygen gradient 
along the HFB in the cell monolayer. It will also allow for the calculation of spatial cell metabolism rates—
either nutrient metabolism or xenobiotic clearance—from samples of the output media alone. In addition 
the mathematical model could interpret changes in oxygen consumption as an early indicator of toxicity 
within the HFB. This is through the use of oxygen probe data from the output media to determine the key 
time points when toxic events are beginning to impact upon cell function. The mathematical analysis also 
shows that the concentration within the ECS is constant radially and will be approximately the same as the 
unbound concentration in the cells at any given point along the length of the bioreactor. Measuring the 
concentration in the ECS at the inlet and outlet ends of the HFB will give a more relevant measurement for 
calculating the metabolism rate of the cells than the lumen concentration. This may influence the design of 
the bioreactor.   
Simulations of a HFB containing a monolayer of cells that have APAP elimination rates calculated from 
hepatocytes under different conditions—in vivo, suspension and microfluidic—show considerable 
differences in the total clearance within the HFB. This means that any improvement in the functionality of 
  
21 
 
cells over those in 2D cultures should produce a measurable change in the total clearance in the HFB for 
our APAP test compound. This will allow us to quantitatively compare the HFB to 2D cultures and other 
systems, and such in vitro to in vivo extrapolations for human primary cells and cell lines will be a focus of 
our future work. 
Analysing how the parameters of the HFB model change APAP clearance under the condition of maintaining 
the same oxygen gradient has revealed some important insights into the design of the HFB. First of all, HFBs 
of different lengths but with the same oxygen gradient will have identical APAP gradients. This means the 
length of the HFB can be chosen on other considerations for example cell number or convenience of 
production. Secondly, altering the radius of the lumen does not greatly change the predicted clearance of 
APAP. Again this is another parameter that can be chosen without considering the effect on compound 
clearance. Thirdly, compound clearance is highly sensitive to the membrane depth and diffusion hindrance 
factor. These are key parameters for the HFB as changes in the hindrance factor of the membrane may 
result from protein and compound fouling and there may be variability in pore size and tortuosity between 
batches of fibres. Our results show a HFB with a thin membrane will have higher APAP clearance than a HFB 
with a thicker membrane, under the condition that the HFBs are set up to have the same oxygen 
concentration gradient at the cells and the same input APAP concentration. How this relationship alters 
with compounds of different sizes and intrinsic clearances will have an impact on the development of the 
membrane materials and production method.  
Overall, in better recapitulating the graded hepatic sinusoid oxygen microenvironment, HFB have the 
potential to provide more efficient, sensitive and specific tests of liver function and potential toxicity. The 
mathematical modelling of the HFB presented here will speed up bioreactor development, aid in 
experimental design and operation, allow for quantitative assessment between systems and give improved 
in vitro to in vivo extrapolations. We have identified the key parameters in the design of the HFB that 
impact on xenobiotic clearance—membrane depth, hindrance factor and cell density—and shown that 
these factors are only important if there is a significant xenobiotic concentration gradient in the HFB 
through either a low dose or low clearance rate. The parameters identified as not impacting significantly on 
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xenobiotic clearance are lumen radius and length. We have also produced novel analytic results that allow 
the mathematical model to be employed by non-specialists without the need for proprietary software. 
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